John C. Krauss

9.5k citations
120 papers · 6.8k · 5 hit papers · h-index 34

Impact in

  • Oncology top 0.5%
    • Colorectal Cancer Surgical Treatments
    • Colorectal Cancer Treatments and Studies
    • CAR-T cell therapy research
    • Cancer Immunotherapy and Biomarkers
    • Pancreatic and Hepatic Oncology Research
    • Cancer Genomics and Diagnostics

Papers in

    • CAR-T cell therapy research 13
    • Colorectal Cancer Treatments and Studies 13
    • Cancer Immunotherapy and Biomarkers 8
    • Immunotherapy and Immune Responses 20

John C. Krauss

117 papers receiving 6.6k citations

John C. Krauss's Hit Papers

Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study 2023 · 219 citations
2190+2+4Years since publication4008001.2k

Peers

John C. Krauss
Comparison fields: 5 of 137
  • Oncology 3.2k
  • Cancer Research 888
  • Genetics 565
  • Pathology and Forensic Medicine 820
  • Pulmonary and Respiratory Medicine 1.4k
Replace Lia Gore with:
Lia Gore United States
Günter Schlimok Germany
Jacques Médioni France
Benjamin Esterni France
John C. Gutheil United States
Shumei Kato United States
Thierry Lesimple France
Valentina Boni Spain
Emma Clark United Kingdom
Ming‐Tseh Lin United States
John C. Krauss relative to Lia Gore United States Lia Gore's profile →
Citations per field
00.5×1.5×1.8×
Lia Gore · 1×
Citations per year

Countries citing papers authored by John C. Krauss

Since Specialization
Citations

This map shows the geographic impact of John C. Krauss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C. Krauss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C. Krauss more than expected).

Fields of papers citing papers by John C. Krauss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John C. Krauss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C. Krauss. The network helps show where John C. Krauss may publish in the future.

Co-authors

The 25 scholars most cited alongside John C. Krauss, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John C. Krauss Line = papers co-authored together John C. Krauss links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 120 papers — load more, or switch the sort, to bring in the rest.

#Work
1
KRAS G12C Inhibition with Sotorasib in Advanced Solid Tumors
Hit paper breakdown →
20201339
2
Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials
Hit paper breakdown →
20191330
3
Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy
Hit paper breakdown →
2022596
4
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study
Hit paper breakdown →
2023219
5 1998213
6
Long-Term Results of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy: The Randomized Phase II OPRA Trial
Hit paper breakdown →
2023200
7 2014155
8 2010149
9 2005148
10 2011145
11 1998124
12 199499
13 199690
14 201482
15 201271
16
Isolation based on L-selectin expression of immune effector T cells derived from tumor-draining lymph nodes.
199670
17 202468
18
Therapeutic efficacy of T cells derived from lymph nodes draining a poorly immunogenic tumor transduced to secrete granulocyte-macrophage colony-stimulating factor.
199660
19 201059
20 199558

About John C. Krauss

John C. Krauss is a scholar working on Oncology, Immunology, Pathology and Forensic Medicine, Family Practice and Pulmonary and Respiratory Medicine, having authored 120 papers that have together received 6.8k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (20 papers), CAR-T cell therapy research (13 papers), Colorectal Cancer Treatments and Studies (13 papers), Monoclonal and Polyclonal Antibodies Research (10 papers), Lung Cancer Treatments and Mutations (10 papers), Virus-based gene therapy research (9 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Lymphoma Diagnosis and Treatment (8 papers). The work is most often cited by research in Oncology (3.2k citations), Cancer Research (888 citations), Genetics (565 citations), Pathology and Forensic Medicine (820 citations) and Pulmonary and Respiratory Medicine (1.4k citations). John C. Krauss has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Hartmut Collmann, Natalie Sorensen, Wei Chen, Xuetao Cao, Jianli Wang, Robert F. Todd, Liaomin Peng, Suyu Shu, Laura Mayo-Bond and Shengnan Shu. Their work appears in journals such as Annals of Oncology, Blood, Journal of Clinical Oncology, Child s Nervous System and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact